160 related articles for article (PubMed ID: 16831943)
1. Mechanisms involved in skeletal anabolic therapies.
Martin TJ; Quinn JM; Gillespie MT; Ng KW; Karsdal MA; Sims NA
Ann N Y Acad Sci; 2006 Apr; 1068():458-70. PubMed ID: 16831943
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
Goltzman D
Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells.
Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N
J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231
[TBL] [Abstract][Full Text] [Related]
4. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
5. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
[TBL] [Abstract][Full Text] [Related]
6. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
Wang Y; Qin QH; Kalyanasundaram S
Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
8. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development.
Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402
[TBL] [Abstract][Full Text] [Related]
9. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone.
Komarova SV
Endocrinology; 2005 Aug; 146(8):3589-95. PubMed ID: 15860557
[TBL] [Abstract][Full Text] [Related]
10. Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP).
Liao J; McCauley LK
Cancer Metastasis Rev; 2006 Dec; 25(4):559-71. PubMed ID: 17165129
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone: past and present.
Potts JT
J Endocrinol; 2005 Dec; 187(3):311-25. PubMed ID: 16423810
[TBL] [Abstract][Full Text] [Related]
12. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
13. Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.
Koh AJ; Demiralp B; Neiva KG; Hooten J; Nohutcu RM; Shim H; Datta NS; Taichman RS; McCauley LK
Endocrinology; 2005 Nov; 146(11):4584-96. PubMed ID: 16081645
[TBL] [Abstract][Full Text] [Related]
14. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
15. Anabolic effects of intermittent PTH on osteoblasts.
Greenfield EM
Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
[TBL] [Abstract][Full Text] [Related]
16. Response to continuous and pulsatile PTH dosing: a mathematical model for parathyroid hormone receptor kinetics.
Potter LK; Greller LD; Cho CR; Nuttall ME; Stroup GB; Suva LJ; Tobin FL
Bone; 2005 Aug; 37(2):159-69. PubMed ID: 15921971
[TBL] [Abstract][Full Text] [Related]
17. New mechanisms and targets in the treatment of bone fragility.
Martin TJ; Seeman E
Clin Sci (Lond); 2007 Jan; 112(2):77-91. PubMed ID: 17155930
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone is essential for normal fetal bone formation.
Miao D; He B; Karaplis AC; Goltzman D
J Clin Invest; 2002 May; 109(9):1173-82. PubMed ID: 11994406
[TBL] [Abstract][Full Text] [Related]
19. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro.
de Gortázar AR; Alonso V; Alvarez-Arroyo MV; Esbrit P
Calcif Tissue Int; 2006 Nov; 79(5):360-9. PubMed ID: 17120184
[TBL] [Abstract][Full Text] [Related]
20. [Hormones and osteoporosis update. Histological aspects on the action of parathyroid hormone (PTH) and PTH-related peptide (PTHrP) on bone and cartilage].
Amizuka N; Li M; Tamura M; Oda K
Clin Calcium; 2009 Jul; 19(7):935-43. PubMed ID: 19567988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
